Lu H S, Hsu Y R, Narhi L O, Karkare S, Lin F K
Amgen Center, Amgen Inc., Thousand Oaks, California, 91320, USA.
Protein Expr Purif. 1996 Sep;8(2):227-37. doi: 10.1006/prep.1996.0095.
We report here the expression of recombinant human prokallikrein and kallikrein in engineered Chinese hamster ovary cells transfected with a human genomic gene encoding preprokallikrein. At high expression levels, recombinant prokallikrein, an inactive proenzyme form, is predominantly secreted into the culture medium. Upon chromatographic separations, the inactive prokallikrein as well as the mature kallikrein after thermolysin activation of the proenzyme can be prepared to apparent purity. Both prokallikrein and kallikrein can be further separated into two distinct high- and low-molecular-weight isoforms. Kallikrein preparations are fully active in standard kallikrein activity assays such as esterase activity and kinin release from kininogen. Both kallikrein and prokallikrein display multiple molecular forms with differences in both molecular sizes and charges. The structural differences in high- and low-molecular-weight kallikreins or prokallikreins were found to be due to glycosylation, with the high-molecular-weight species glycosylated at three Asn-linked sites and the low-molecular-weight species at two of the three Asn-linked sites. The multiply charged kallikrein isoforms are derived from different numbers of sialic acids attached at the detected Asn-linked carbohydrates. In comparison with kallikrein, prokallikrein appears to show a significant decrease in the magnitude of near uv-circular dichroism bands, suggesting a change in local conformation. This conformational change correlates with the loss of activity in proenzyme due to the presence of propeptide.
我们在此报告,在转染了编码前激肽释放酶原的人类基因组基因的工程化中国仓鼠卵巢细胞中,重组人激肽释放酶原和激肽释放酶的表达情况。在高表达水平时,重组激肽释放酶原(一种无活性的酶原形式)主要分泌到培养基中。经过色谱分离后,可以将无活性的激肽释放酶原以及酶原经嗜热菌蛋白酶激活后的成熟激肽释放酶制备到接近纯品的状态。激肽释放酶原和激肽释放酶都可以进一步分离成两种不同的高分子量和低分子量同工型。激肽释放酶制剂在标准的激肽释放酶活性测定中,如酯酶活性和从激肽原释放激肽的活性测定中,具有完全活性。激肽释放酶和激肽释放酶原都显示出多种分子形式,在分子大小和电荷方面都存在差异。发现高分子量和低分子量激肽释放酶或激肽释放酶原的结构差异是由于糖基化造成的,高分子量形式在三个天冬酰胺连接位点进行了糖基化,而低分子量形式在三个天冬酰胺连接位点中的两个位点进行了糖基化。带多个电荷的激肽释放酶同工型源自于在检测到的天冬酰胺连接碳水化合物上连接的不同数量的唾液酸。与激肽释放酶相比,激肽释放酶原在近紫外圆二色性带的强度上似乎有显著降低,这表明局部构象发生了变化。这种构象变化与由于前肽的存在而导致的酶原活性丧失相关。